COSTCHECK
LIVE

Serial Number

97853121

Owner

BLUESIGHT, INC.

Attorney

Gregory B. Phillips

Filing Date

Mar 23, 2023

Add to watchlist:

No watchlists yet
View on USPTO

COSTCHECK Trademark

Serial Number: 97853121

COSTCHECK is a trademark filed by BLUESIGHT, INC. on March 23, 2023. The trademark is classified under Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

BLUESIGHT, INC. (19 trademarks)

1800 DUKE ST STE 108
ALEXANDRIA, VA 22134

Entity Type: 03

KitCheck, Inc. (5 trademarks)

1800 Duke St Ste 108
Alexandria, VA 22314

Entity Type: 03

Trademark Details

Filing Date

March 23, 2023

Registration Date

Not Registered

Published for Opposition

September 17, 2024

Goods & Services

Electronic data collection, management, analysis, and display services being a form of analysis of market research data through data visualization for business purposes, namely, in the fields of medicine, healthcare, pharmaceuticals, and biotechnology; Business services provided to the medical, healthcare, pharmaceutical, and biotechnology industries, namely, the collection, reporting, and analysis of healthcare and pharmaceutical quality data for business purposes

Data Warehousing; Providing temporary use of non-downloadable computer software for supply chain management of pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for monitoring purchasing trends and pricing for pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information regarding cost-effective alternatives and products for pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information and recommendations regarding purchasing pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information and recommendations regarding cost-effective alternatives and products in connection with purchasing pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information and recommendations regarding cost-effective alternative suppliers in connection with purchasing pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information and recommendations regarding alternatives to help alleviate or respond to pharmaceutical, vaccine and medication shortages; Providing temporary use of non-downloadable computer software for providing information and recommendations regarding compliance with contracts, discount programs, and rebates in connection with purchasing pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for assessing, reviewing, and auditing prescription and medication records; Providing temporary use of non-downloadable computer software for assessing, reviewing, and auditing prescription and medication records in connection with purchase pricing, budgeting, discounts, and rebates; Providing temporary use of non-downloadable computer software for assessing, reviewing, and auditing prescription and medication records in connection with contract compliance and Group Purchasing Organizations (GPO) compliance; Providing temporary use of non-downloadable computer software for assessing, reviewing and reporting data trends found in prescription and medication records; Providing temporary use of non-downloadable computer software for monitoring, tracking, and taking inventory of pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for use in supply chain management of pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for monitoring purchasing trends and pricing for pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for providing information regarding cost-effective alternatives and products for pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for providing information and recommendations regarding purchasing pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for providing information and recommendations regarding cost-effective alternatives and products in connection with purchasing pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for providing information and recommendations regarding cost-effective alternative suppliers in connection with purchasing pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for providing information and recommendations regarding alternatives to help alleviate or respond to pharmaceutical, vaccine and medication shortages; Software as a service (SAAS) services featuring software for providing information and recommendations regarding compliance with contracts, discount programs, and rebates in connection with purchasing pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for assessing, reviewing, and auditing prescription and medication records; Software as a service (SAAS) services featuring software for assessing, reviewing, and auditing prescription and medication records in connection with purchase pricing, budgeting, discounts, and rebates; Software as a service (SAAS) services featuring software for assessing, reviewing, and auditing prescription and medication records in connection with contract compliance and Group Purchasing Organizations (GPO) compliance; Software as a service (SAAS) services featuring software for assessing, reviewing and reporting data trends found in prescription and medication records; Software as a service (SAAS) services featuring software for monitoring, tracking, and taking inventory of pharmaceuticals, vaccines, and medications

Filing History

STATEMENT OF USE PROCESSING COMPLETE
May 12, 2026 SUPC
USE AMENDMENT FILED
Dec 30, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 30, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 13, 2025 EXRA
SOU EXTENSION 2 GRANTED
Nov 12, 2025 EX2G
SOU EXTENSION 2 FILED
Nov 12, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 12, 2025 EEXT
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
May 19, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 19, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 19, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 19, 2025 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 2, 2025 EXRA
SOU EXTENSION 1 GRANTED
May 2, 2025 EX1G
SOU EXTENSION 1 FILED
May 2, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
May 1, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 12, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 17, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 17, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 28, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 9, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 14, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 14, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 14, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Mar 14, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Mar 14, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 3, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 3, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 3, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 18, 2023 DOCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 20, 2023 ASGN
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 14, 2023 NWOS
NEW APPLICATION ENTERED
Mar 27, 2023 NWAP